Teleflex Receives FDA Clearance For ARROW-ClarkTM VectorFlow Chronic Hemodialysis Catheter

Teleflex Incorporated

, a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW-Clark™ VectorFlow™ Chronic Hemodialysis Catheter. Designed by Dr. Timothy Clark, M.D., the VectorFlowTM Catheter features a symmetrical tip design that allows ease of placement and sustained high flows with minimal recirculation. “Providing clinicians with the ARROW-Clark™ VectorFlow™ Catheter continues a series of new product introductions that demonstrates our commitment to enhance patient outcomes and improve ease of use for clinicians,” said Linda Beneze, President and General Manager, Specialty Division. “We are proud to add the VectorFlow™ Catheter to our portfolio.” The ARROW-Clark™ VectorFlow™ Catheter is the only catheter with an innovative tip designed to produce a helical, three-dimensional transition of blood entering and leaving the catheter.1